Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can occur because of the menopause or because of hormone treatment for breast cancer. Now, a new analysis of data from the trial shows that it also gives sustained relief regardless of the type of hormone treatment cancer patients receive.
This article was originally published on MedicalXpress.com

